Country | National Surveillance | Reporting to WHO-GASP | Challenges mentioned to participating in WHO-GASP |
---|---|---|---|
Albania | No | No | N/A |
Andorra | No | No | N/A |
Armenia | No | No | Lack of national AMR surveillance programs, Resource limitations, Technical expertise and capacity gaps, Limited coordination mechanisms |
Azerbaijan | No | No | N/A |
Belarus | No | Noa | N/A |
Georgia | Yes | No | N/A |
Israel | Yes | Noa | N/A |
Kyrgyzstan | No | Noa | N/A |
Monaco | No | No | N/A |
Montenegro | No | No | No referent laboratory, Low testing rates, Limited number of isolates |
North Macedonia | Yes | No | No information on how to report to WHO GASP |
Republic of Moldova | No | No | Lack of infrastructure |
San Marino | No | Unknown | N/A |
Serbia | No | No | No national program, No national reference laboratory |
Switzerland | Yes | Yes | N/A |
Tajikistan | No | Unknown | N/A |
Türkiye | No | Unknown | N/A |
Ukraine | No | Noa | Lack of a single electronic data collection system, Insufficient provision of laboratory reagents, Lack of requirements |
Uzbekistan | No | Unknown | N/A |